A brand new DIA Conference featuring an expert programme committee and speakers from the EMEA, CHMP Working Group, EFPIA, European Commission, EBE, EuropaBio, Eucomed and senior representatives from industry.
The conference will involve all stakeholders including regulators, industry, academia and patient groups.
The conference is organised over two days. The first day will address the progress with the implementation of the Innovative Medicines Initiative and the EMEA initiatives in relation to support innovation including the qualification of biomarkers and new methodologies. The second day will focus on the practical aspects to implement the Regulation on Advanced Therapy.